abstract |
This invention provides methods of treating an abnormality that is linked to the activity of the mammalian SNORF55 receptor, as well as methods of determining binding of compounds to the mammalian SNORF55 receptor, methods of identifying agonists and antagonists of the SNORF55 receptor, and agonists and antagonists so identified. |